| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2575824 | The American Journal of Geriatric Pharmacotherapy | 2010 | 14 Pages |
Abstract
Conclusions: For elderly patients with type 2 DM, reductions in HbA1c after treatment with a DPP-4 inhibitor were not significantly different from those in younger patients. Use of DPP-4 inhibitors in these studies was associated with a low risk of hypoglycemia, and these agents were weight neutral.
Related Topics
Health Sciences
Medicine and Dentistry
Geriatrics and Gerontology
Authors
Sherwyn L. MD,